Improved treatment outcome of primary mediastinal large B-cell lymphoma after introduction of rituximab in Korean patients

International Journal of Hematology

Volumn 91, Issue 3, 2010, Pages 456-463

  Ahn, Hee Kyung ^a   Kim, Seok Jin ^a   Yun, Jina ^a   Yi, Jun Ho ^a   Kim, Jung Hoon ^a   Won, Young Woong ^a   Kim, Kihyun ^a   Ko, Young Hyeh ^a   Kim, Won Seog ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Mediastinal large B cell lymphoma; Prognosis; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER RELAPSE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KOREA; LARGE CELL LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIMARY MEDIASTINAL LARGE CELL LYMPHOMA; PROGNOSIS; PROGRESSION FREE SURVIVAL; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDNISONE; PROGNOSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE; YOUNG ADULT;

EID: 77950916558     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0536-6     Document Type: Article

References (23)

1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma 1997 The Non-Hodgkin's Lymphoma Classification Project Blood 89 3909 3918
2. M Lazzarino E Orlandi M Paulli J Strater C Klersy U Gianelli, et al. 1997 Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients J Clin Oncol 15 1646 1653 1:STN:280:DyaK2szjs1Kiug%3D%3D 9193365 (Pubitemid 27167405)
3. WJ Hofmann F Momburg P Moller 1988 Thymic medullary cells expressing B lymphocyte antigens Hum Pathol 19 1280 1287 10.1016/S0046-8177(88)80282-X 1:STN:280:DyaL1M%2Fjt1ejtw%3D%3D 3263309 (Pubitemid 19005628)
4. G Todeschini S Secchi E Morra U Vitolo E Orlandi F Pasini, et al. 2004 Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B Br J Cancer 90 372 376 10.1038/sj.bjc.6601460 1:CAS:528:DC%2BD2cXksl2ntg%3D%3D 14735179 (Pubitemid 38250631)
5. PA Hamlin CS Portlock DJ Straus A Noy A Singer SM Horwitz, et al. 2005 Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999 Br J Haematol 130 691 699 10.1111/j.1365-2141.2005.05661.x 16115124 (Pubitemid 43916303)
6. KR Calvo A Traverse-Glehen S Pittaluga ES Jaffe 2004 Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma Adv Anat Pathol 11 227 238 10.1097/01.pap.0000138144.11635.f8 1:CAS:528:DC%2BD2cXnvFKgtbw%3D 15322489
7. A Rosenwald G Wright K Leroy X Yu P Gaulard RD Gascoyne, et al. 2003 Molecular diagnosis of primary mediastinal B-cell lymphoma identifies a clinically favorable subgroup of diffuse large B-cell lymphoma related to Hodgkin lymphoma J Exp Med 198 851 862 10.1084/jem.20031074 1:CAS:528: DC%2BD3sXnsV2ntL4%3D 12975453 (Pubitemid 37152922)
8. S Bieri E Roggero E Zucca F Bertoni S Pianca P Sanna, et al. 1999 Primary mediastinal large B-cell lymphoma (PMLCL): the need for prospective controlled clinical trials Leuk Lymphoma 35 139 146 10.1080/10428199909169618 1:STN:280:DyaK1MvktVOhsA%3D%3D 10512171 (Pubitemid 29454411)
9. KJ Savage N Al-Rajhi N Voss C Paltiel R Klasa RD Gascoyne, et al. 2006 Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience Ann Oncol 17 123 130 10.1093/annonc/mdj030 1:STN:280:DC%2BD2MnntFKiuw%3D%3D 16236753 (Pubitemid 43033851)
10. PL Zinzani M Martelli M Bertini AM Gianni L Devizzi M Federico, et al. 2002 Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients Haematologica 87 1258 1264 1:CAS:528:DC%2BD3sXnvFagtg%3D%3D 12495899 (Pubitemid 36005300)
11. M Pfreundschuh L Trumper A Osterborg R Pettengell M Trneny K Imrie, et al. 2006 CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group Lancet Oncol 7 379 391 10.1016/S1470-2045(06)70664-7 1:CAS:528: DC%2BD28XjvFWlsbw%3D 16648042
12. BD Cheson SJ Horning B Coiffier MA Shipp RI Fisher JM Connors, et al. 1999 Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI-Sponsored International Working Group J Clin Oncol 17 1244 1:STN:280:DC%2BD3c%2FivF2itg%3D%3D 10561185
13. M Schemper TL Smith 1996 A note on quantifying follow-up in studies of failure time Control Clin Trials 17 343 346 10.1016/0197-2456(96)00075-X 1:STN:280:DyaK2s%2FksVaktA%3D%3D 8889347 (Pubitemid 26342716)
14. M Trneny M Rieger A Osterborg R Pettengel DJ White D Gill, et al. 2008 The addition of rituximab eliminates the negative prognostic impact of PMBCL compared to DLBCL in young patients with CD20-positive aggressive lymphomas receiving a CHOP-like chemotherapy: results of a subgroup analysis of the Mabthera International Trial Group (MInT) Study Blood 112 311
15. A Avigdor T Sirotkin N Shemtov M Berkowicz Y Davidovitz A Kneller, et al. 2007 Combination of rituximab with initial chemotherapy improves outcome of primary mediastinal B-cell lymphoma: a retrospective analysis of a single institution cohort Blood 110 386A
16. K Dunleavy S Pittaluga J Janik N Grant M Shovlin S Steinberg, et al. 2006 Primary mediastinal large B-cell lymphoma (PMBL) outcome may be significantly improved by the addition of rituximab to dose-adjusted (DA)-EPOCH and obviates the need for radiation: results from a prospective study of 44 patients Blood 108 66A
17. R Mazzarotto C Boso F Vianello MS Aversa V Chiarion-Sileni L Trentin, et al. 2007 Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience Int J Radiat Oncol Biol Phys 68 823 829 1:CAS:528:DC%2BD2sXmtVamt70%3D 17379431 (Pubitemid 46818727)
18. PL Zinzani M Martelli M Magagnoli E Pescarmona L Scaramucci F Palombi, et al. 1999 Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients Blood 94 3289 3293 1:CAS:528: DyaK1MXnsVagtb4%3D 10552937 (Pubitemid 29536121)
19. PL Zinzani M Martelli V Poletti U Vitolo PG Gobbi T Chisesi, et al. 2008 Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation Haematologica 93 1364 1371 10.3324/haematol.12742 1:CAS:528:DC%2BD1cXhtl2gur7O 18603558
20. AA Abou-Elella DD Weisenburger JM Vose JP Kollath JC Lynch MA Bast, et al. 1999 Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group J Clin Oncol 17 784 790 1:STN:280:DyaK1M7mvVyhtw%3D%3D 10071267
21. D Cazals-Hatem E Lepage P Brice A Ferrant MF d'Agay E Baumelou, et al. 1996 Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study Am J Surg Pathol 20 877 888 10.1097/00000478-199607000-00012 1:STN:280:DyaK283msFSjtQ%3D%3D 8669537 (Pubitemid 26230752)
22. PL Zinzani M Martelli M Bendandi A De Renzo A Zaccaria E Pavone, et al. 2001 Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy Haematologica 86 187 191 1:CAS:528:DC%2BD3MXisVygtL4%3D 11224489 (Pubitemid 32216093)
23. N Sekiguchi J Nishimoto K Tanimoto S Kusumoto Y Onishi T Watanabe, et al. 2004 Primary mediastinal large B-cell lymphoma: a single-institution clinical study in Japan Int J Hematol 79 465 471 10.1532/IJH97.03173 15239397 (Pubitemid 38808363)